|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Prepaid expenses and other | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Investment in equity securities | ||||||||||||||||||||
| Deferred financing costs | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Land and buildings, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Mineral properties | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Current | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Deferred reimbursements | ||||||||||||||||||||
| Warrant liabilities, at fair value | ||||||||||||||||||||
| Related party debt | ||||||||||||||||||||
| Convertible debt | ||||||||||||||||||||
| Earnout liability, at fair value | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Non-current | ||||||||||||||||||||
| Warrant liabilities, at fair value | ||||||||||||||||||||
| Earnout liability, at fair value | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interest | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Common stock, no par value, unlimited shares authorized; 145,838,380 and 58,491,196 shares outstanding, respectively | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities, redeemable noncontrolling interest, and shareholders' equity | ||||||||||||||||||||
Loading...
